Antisense oligonucleotide mediated therapy of spinal muscular atrophy
Open Access
- 1 January 2013
- journal article
- Published by Walter de Gruyter GmbH in Translational Neuroscience
- Vol. 4 (1) , 1-7
Abstract
Spinal muscular atrophy (SMA) is the leading genetic cause of infant mortality. SMA results from deletions or mutations of survival motor neuron 1 (SMN1), an essential gene. SMN2, a nearly identical copy, can compensate for SMN1 loss if SMN2 exon 7 skipping is prevented. Among the many cis-elements involved in the splicing regulation of SMN exon 7, intronic splicing silencer N1 (ISS-N1) has emerged as the most effective target for an antisense oligonucleotide (ASO)-mediated splicing correction of SMN2 exon 7. Blocking of ISS-N1 by an ASO has been shown to fully restore SMN2 exon 7 inclusion in SMA patient cells as well as in vivo. Here we review how ISS-N1 targeting ASOs that use different chemistries respond differently in the various SMA mouse models. We also compare other ASO-based strategies for therapeutic splicing correction in SMA. Given that substantial progress on ASO-based strategies to promote SMN2 exon 7 inclusion in SMA has been made, and that similar approaches in a growing number of genetic diseases are possible, this report has wide implications.Keywords
This publication has 70 references indexed in Scilit:
- U1 snRNP Determines mRNA Length and Regulates Isoform ExpressionCell, 2012
- Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular AtrophyMolecular Therapy, 2012
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyThe Lancet, 2011
- Early Functional Impairment of Sensory-Motor Connectivity in a Mouse Model of Spinal Muscular AtrophyNeuron, 2011
- Expansion of the eukaryotic proteome by alternative splicingNature, 2010
- Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophyBiochemical and Biophysical Research Communications, 2010
- Vascular Perfusion Abnormalities in Infants with Spinal Muscular AtrophyThe Journal of Pediatrics, 2009
- The Spliceosome: Design Principles of a Dynamic RNP MachineCell, 2009
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic MiceThe American Journal of Human Genetics, 2008
- Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot projectNature, 2007